IGM Biosciences Inc. (Nasdaq: IGMS) of Mountain View said Thursday that it plans to cut roughly 160 of its 220-person workforce and stop development of two drugs. Meanwhile, privately held Scribe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback